COMMISSION DECISION of 17 July 1995 modifying Commission Decision 94/827/EC of 20 December 1994 on the allocation of quantities of controlled substances allowed for essential uses for 1995, under Council Regulation (EC) No 3093/94 on substances that deplete the ozone layer (95/286/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES;

Having regard to the Treaty establishing the European Community, especially Article 130s,

Having regard to the Council Regulation (EC) No 3093/94 of 15 December 1994 on substances that deplete the ozone layer (1),

Having regard to the enlargement of the European Community with the three new Member States of Austria, Finland and Sweden,

Whereas quantities of controlled substances allowed for essential uses in Austria, Finland and Sweden for 1995 need to be allocated;

Whereas those essential uses have to be decided for chlorofluorocarbons, as per Articles 3 (1) and 4 (1), fully halogenated chlorofluorocarbons, as per Articles 3 (2) and 4 (2), halons as per Articles 3 (3) and 4 (3), carbon tetrachloride, as per Articles 3 (4) and 4 (4), as well as Article 7 (4) of Regulation (EC) No 3093/94;

Whereas the Commission has published Decision 94/827/EC (2) on the allocation of quantities of controlled substances allowed for essential uses in the Community in 1995 for the then 12 Member States of the European Union for 1995;

Whereas a limited number of corrections which have been approved by the Article 16 Committee of Regulation (EC) No 3093/94, have to be made to Decision 94/827/EC;

Whereas the Technology and Economic Assessment Panel (TEAP) of UNEP recommends a general blanket exemption for essential uses for laboratory purposes, this Decision contains a reserve quantity of controlled substances for this purpose to meet the potential demands of all users of controlled substances in laboratories;

Whereas in order to meet the essential laboratory uses in the Community, the Commission has identified those distributors who may additionally to those figuring in Decision 94/827/EC, supply the controlled substances for this purpose;

Whereas three companies should not figure in Annex 4 of the abovementioned Commission Decision since they are not distributors of laboratory chemicals;

Whereas Article 16 of Regulation (EC) No 3093/94 sets out the procedure according to which decisions can be taken concerning the implementation of the Regulation;

Whereas the measures provided for in this Decision are in accordance with the opinion of the Committee referred to in Article 16 of the abovementioned Regulation,

HAS ADOPTED THIS DECISION:

Article 1

The present Decision modifies Decision 94/827/EC in light of the enlargement of the Union with the three new Member States Austria, Finland and Sweden, and in view of a limited number of necessary corrections.

Article 2

Those companies who may additionally to those presented in Decision 94/827/EC, take advantage of those essential uses for their own account in 1995 are presented in Annex 2. The additional allocation of quantities of chlorofluorcarbons 11, 12, 113, 114 and 115 (the total additional quantity allocated being 86,9 tonnes), other fully halogenated chlorofluorocarbons (the total additional quantity allocated being 0/tonnes), halons (the total additional quantity allocated being 0/tonnes) and carbon tetrachloride (the total additional quantity allocated being 20,2 tonnes) during the period 1 January to 31 December 1995 shall be as indicated in the Annex 3 (3) hereto.

Article 3

Those companies who may, additionally to those presented in Annex 4 of Decision 94/827/EC, take advantage of the essential uses exemption for the use of controlled substances as laboratory uses in the Community in 1995, are presented in Annex 4.

The quantity of chlorofluorocarbons allowed for essential use in laboratories will be increased by 24 tonnes and the quantity of carbon tetrachloride allowed for essential use in laboratories will be increased by 25 tonnes

Article 4

The following companies should be deleted from Annex 4 of Decision 94/827/EC since they cannot be qualified as distributors of laboratory chemicals: 'Miramed`, 'Fiat Avio Spa` and 'Studio Chiono SRL`.

Article 5

1. This Decision is addressed to the companies listed in Annex 1.

2. This Decision shall apply from 1 January 1995 to 31 December 1995.

Done at Brussels, 17 July 1995.

For the Commission

Ritt BJERREGAARD

Member of the Commission

(1) OJ No L 333, 22. 12. 1994, p. 1.

(2) OJ No L 350, 31. 12. 1994, p. 126.

(3) Annex 3 is not published because it contains commercially sensitive information.

ANEXO 1 - BILAG 1 - ANHANG 1 - ÐÁÑÁÑÔÇÌÁ 1 - ANNEX 1 - ANNEXE 1 - ALLEGATO 1 - BIJLAGE 1 - ANEXO 1 - LIITE 1 - BILAGA 1

Chemie Linz GesmbH

St. Peterstraße 25

A-4021 Linz

Dipl. Ing. Fritz Gatt

Müllerstraße 10

A-6010 Innsbruck

Hafslund Nicomed Pharma

Dr. H. K. Vorreither

St. Peter-Straße 25

A-4020 Linz

Jaba Farmaceutica

Apartado 165

Abrunheira

P-2710 Sintra

Kebo Lab Oy

Pia Selenius

S-163 94 Spånga

Lactan

Zinzndorfgasse 12

A-8011 Graz

Leiras Oy

Lasse Vuorinen

PL 415

FIN-20101 Turku

Merck GesmbH

Zimbagasse 5

A-1147 Wien

Merck (D)

Frankfurter Straße 250

D-64293 Darmstadt

Kebo Lab Oy

Ilkka Sirén

Niittyrinne 7

FIN-02270 Espoo

Orion-Farmos

Pasi Salokangas

Orionintie 1

PL 65

FIN-02101 Espoo

Oy FF-Chemicals Ab

Juha Niskala

FIN-91200 Yli-Ii

Riedel-de Haën

Dr. H. Gattner

Aktiengesellschaft

Postfach 100262

D-30918 Seelze

Tamro Corporation

Sakari Boman

PL 11 (Rajatorpantie 41B)

FIN-01641 Vantaa

Ya-Kemia Ltd

Timo Posti

Kalliolanrinne 6

FIN-00510 Helsinki

W. J. Rohrbeck's Nachf.

Wehrgasse 18

A-1052 Wien

W. Neuber's Enkel

Linke Wienzeile 152

A-1060 Wien

ANNEX 2

>START OF GRAPHIC>

A. MEDICAL USES

Production of metered dose inhalers (MDIs) for the treatment of asthma and other chronic obstructive pulmonary diseases CFC 11, CFC 12, CFC 113, CFC 114, CFC 115.

Company

Hafslund Nycomed Pharma (A)

Jaba Farmaceutica (P)

Leiras (FIN)

Orion-Farmos (FIN)

C. LABORATORY USES

C.1. CFC's:

Company

W. Neuber's Enkel (A)

Merck GesmbH (A)

Lactan (A)

Chemie Linz GesmbH (A)

Dipl. Ing. Fritz Gatt (A)

W. J. Rohrbeck's Nachf. (A)

Merck (D) on behalf of Kebo Lab (S)

Kebo Lab Oy (FIN)

Oy FF-Chemicals Ab (FIN)

Tamro Corporation (FIN)

C.2. Carbon tetrachloride (CCl4):

Company

W. Neuber's Enkel (A)

Merck GesmbH (A)

Lactan (A)

Chemie Linz GesmbH (A)

Dipl. Ing. Fritz Gatt (A)

W. J. Rohrbeck's Nachf. (A)

Merck (D) on behalf of Kebo Lab (S)

Kebo Lab Oy (FIN)

Oy FF-Chemicals Ab (FIN)

Riedel (D)

Tamro Corporation (FIN)

Ya-Kemia Ltd (FIN)

Additional (1) quantity for laboratory uses:

- CFCs: 24 tonnes

- Carbon Tetrachloride: 25 tonnes

(1) To Commission Decision 94/563/EC (OJ No L 215, of 20. 8. 1994, p. 21).

>END OF GRAPHIC>

ANEXO 4 - BILAG 4 - ANHANG 4 - ÐÁÑÁÑÔÇÌÁ 4 - ANNEX 4 - ANNEXE 4 - ALLEGATO 4 - BIJLAGE 4 - ANEXO 4 - LIITE 4 - BILAGA 4

Chemie Linz GesmbH

St. Peterstraße 25

A-4021 Linz

Dipl. Ing. Fritz Gatt

Müllerstraße 10

A-6010 Innsbruck

Kebo Lab Oy

Pia Selenius

S-163 94 Spånga

Lactan

Zinzndorfgasse 12

A-8011 Graz

Merck GesmbH

Zimbagasse 5

A-1147 Wien

Merck (D)

Frankfurter Straße 250

D-64293 Darmstadt

Kebo Lab Oy

Ilkka Sirén

Niittyrinne 7

FIN-02270 Espoo

Oy FF-Chemicals Ab

Juha Niskala

FIN-91200 Yli-Ii

Riedel-de Haën

Dr. H. Gattner

Aktiengesellschaft

Postfach 100262

D-30918 Seelze

Tamro Corporation

Sakari Boman

PL 11 (Rajatorpantie 41B)

FIN-01641 Vantaa

Ya-Kemia Ltd

Timo Posti

Kalliolanrinne 6

FIN-00510 Helsinki

W. J. Rohrbeck's Nachf.

Wehrgasse 18

A-1052 Wien

W. Neuber's Enkel

Linke Wienzeile 152

A-1060 Wien